Azunna Anyanwu tested positive for a banned substance during an October out-of-competition drug test, according to a release by the UFC.
Anyanwu lost his Octagon debut to Justin Ledet after earning a contract on Dana White’s Contender Series.
Below is the complete statement:
The UFC organization was notified today that the U.S. Anti-Doping Agency (USADA) has informed Azunna Anyanwu of a potential Anti-Doping Policy violation stemming from an out-of-competition sample collected on October 18, 2017.
USADA, the independent administrator of the UFC Anti-Doping Policy, will handle the results management and appropriate adjudication of this case involving Anyanwu. Under the UFC Anti-Doping Policy, there is a full and fair legal process that is afforded to all athletes before any sanctions are imposed. Additional information will be provided at the appropriate time as the process moves forward.